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from His Majesty King Carl XVI
Gustaf of Sweden at the Stockholm
Concert Hall.
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Readers rate top docs,
scientists, and teachers

Early last year, in anticipation of
the School of Medicine’s bicentennial in 2010, we asked for
your thoughts on the most significant events and personalities
of the school’s first two centuries [See “200 Years of Medicine
at Yale,” Spring 2009].
Dozens of readers responded
to our survey and offered their
opinions, starting with who or
what had the greatest impact
in shaping the school. The
winner hands down was the
creation of the Yale system in
the 1920s, which garnered the
votes of 84.6 percent of our
respondents. Runners-up were
the school’s founding in 1810
(10.8 percent) and the admission of women in 1916 (4.6 percent). Several of you named the
admission of African-Americans,
the thesis requirement, and the
involvement of students in providing health care to uninsured
families in the New Haven community. One alumnus wrote,
“The Yale system treats medical
education like a serious field,
not just a trade, and treats students like serious adults who
have something to contribute.”
The greatest scientific
advance? The finding by the late

Dorothy Horstmann, m.d.,
fw ’43, the John Rodman Paul
Professor Emerita of Epidemiology and Pediatrics, that the
polio virus enters the central
nervous system through the
bloodstream. That finding,
which paved the way for the
Salk vaccine, won the votes
of 50.8 percent. John P. Peters’
transformation of clinical
chemistry into a discipline of
precise quantitative indicators
of disease received 40.7 percent
of the vote. And 8.5 percent
chose the first antiviral drug,
developed by William Prusoff,
ph.d., in the 1950s.
In the clinical realm, 65.6 percent said the first successful
use of penicillin in the United
States was the school’s greatest
clinical advance. The discovery
of nitrogen mustard as a treatment for cancer won the votes
of 23.4 percent; and 10.9 percent
chose the introduction of fetal
heart monitoring in the 1950s.
Among faculty, 41.7 percent of
you said John Fulton possessed
the most extraordinary scientific
mind; 35.4 percent chose Dorothy
Horstmann; and 22.9 percent
chose George Palade.
Among basic science classes,
you were most impressed with
anatomy, although many of
you also named physiology,
pharmacology, and pathology.
Your most memorable clinical
experiences ranged widely—
from physical diagnosis to being
a chief resident, from caring for
victims of a 1950s New Haven
fire to treating patients during
World War II.
Your favorite extracurricular
activities and favorite memories
spanned the gamut from attending and participating in sports,
plays, and musical productions to

the meals you shared with classmates and colleagues; from trips
to sanitariums to going to chapel;
and from meeting and dating
your future spouses to spending
time in the outdoors. Many of
you fondly remember New Haven
pizza. And one of you wrote,
“Do you really think we had time
for extracurricular activities?”
—Charles Gershman

Yale Medicine receives
award of excellence

In the fall of 2007 we asked
freelance writer Jill Max to look
into the status of the physical
exam in medical education and
practice. We’d been hearing
physicians lament the decline of
the physical exam as advanced
technology appeared to be
replacing their ability to glean
insights into health by touching, feeling, and listening. Jill
worked on the article for several
months, interviewing attendings, residents, medical students,
and national experts on medical
education. In January of this year
we learned that the Association
of American Medical College’s
(aamc) Group on Institutional
Advancement had honored her
with a Robert G. Fenley Writing
Award of Excellence for her article, “The Lost Art of the Physical
Exam” [Yale Medicine, Winter
2009]. The award is the highest bestowed by the aamc to
recognize outstanding writing.
Congratulations, Jill.

starting point
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Yale med alums and their chosen career paths
As the alumni reunion in June approached last year, our colleagues in the development and
alumni offices noted that graduates of the School of Medicine had excelled not only in medicine but in other pursuits. Many are outstanding clinicians and scientists, and many have
gone on to serve as deans of medical schools. But they have also become venture capitalists,
politicians, writers, soldiers, and entrepreneurs. To kick off what will become an occasional
series in Yale Medicine, we include in this issue an article about medical school alumni who
have sought to improve health not one patient at a time, but on a grand scale by pursuing
changes in government policy. Over the years alumni have been involved in the creation of
Medicare, launched anti-smoking campaigns, or worked as aides to politicians including
Hillary Rodham Clinton and the late Edward M. Kennedy. In future issues we will explore
other unusual career paths taken by med school graduates.
This series is also a response to what many of you asked for in our recent reader survey—
more news of alumni. We hope this series will help you keep in touch with classmates or perhaps
rekindle old friendships. In any case, we hope you enjoy hearing about what other med school
alumni are doing.
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chronicle news from cedar street

A Nobel for deciphering
the ribosome’s subunit
Thomas Steitz is honored for solving
the structure of a machine that makes
proteins essential to life.

mi c h a el m a r s l a n d
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A few minutes before noon on October 7,
Thomas A. Steitz, ph.d., Sterling
Professor of Molecular Biophysics and
Biochemistry and professor of chemistry, walked into the President’s Room
at Woolsey Hall to sustained applause.
Amid the cheering crowd were his colleagues on the Yale faculty, students and
postdocs in his lab, the staff of his biotech company, Rib-X Pharmaceuticals,
and news reporters and photographers.
A few minutes later Yale President
Richard C. Levin warmly greeted

Structural biologist Thomas Steitz shared the
2009 Nobel Prize for Chemistry in October for
elucidating the structure of the large subunit of
the ribosome, which helps translate dna information into the proteins that make life possible.

Steitz and his wife, Joan A. Steitz,
ph.d., Sterling Professor of Molecular
Biophysics and Biochemistry. Then
Levin took his place at a lectern in front
of a Yale-blue backdrop to say, “It is with
the greatest pride and enthusiasm that I
am here to introduce you to Tom Steitz,
the winner of the 2009 Nobel Prize
in Chemistry.” The news had arrived
at 5:30 that morning in a phone call to
Steitz from Stockholm.
Steitz, a Howard Hughes Medical
Institute (hhmi) investigator, was one
of three scientists recognized by the
Royal Swedish Academy of Sciences for
their work on the ribosome, a complex
of rna and protein found in all cells.
The Academy noted in its statement
that this year’s chemistry prize honors
“studies of one of life’s core processes:
the ribosome’s translation of dna information into life.”
“It is an amazing piece of work,”
Levin said. “It is fundamental, sweat-itout, figure-it-out science. It is like solving a gigantic jigsaw puzzle. This is the
factory that makes the proteins that are
the source of life.”
The other scientists honored were
Venkatraman Ramakrishnan, ph.d.,
fw ’82, of the Medical Research Council
(mrc) Laboratory of Molecular Biology
in England, and Ada E. Yonath, ph.d.,
of the Weizmann Institute of Science
in Israel. Ramakrishnan studied the
smaller of the ribosome’s two subunits,
while Yonath began making crystals
of the ribosome in 1980, and Steitz
concentrated on the ribosome’s larger
subunit starting in 1995. Although the
three teams tackled parallel problems
related to the ribosome, Steitz said, they
worked separately. “We communicated
via papers and meetings.”

5

Steitz offered thanks for the supportive environment at Yale and in
particular to Peter B. Moore, ph.d.,
Sterling Professor of Chemistry and
professor of molecular biophysics and
biochemistry, who worked with him
on the ribosome project. “He has been
a friend and colleague and co-worker
and collaborator for many years. I very
much appreciate his company and
his work and his participation,” Steitz
said. (Ramakrishnan was a postdoctoral fellow with Moore and Donald
M. Engelman, ph.d., Eugene Higgins
Professor of Molecular Biophysics and
Biochemistry, from 1978 to 1982.)
The Steitzes came to Yale in 1970
after three years as fellows at the mrc,
where Francis Crick and James Watson
had elucidated the double-helix structure of dna in 1953. As Levin noted,
“Tom Steitz has a rare family. His wife
Joan is one of the leading scientists at
Yale as well. She is someone we hope
will some day get the same recognition Tom received today.” (Their son,
Jonathan G. Steitz, j.d. ’07, was drafted
from Yale in 2001 by the Milwaukee
Brewers as a right-handed pitcher, but
tendonitis in his right shoulder ended
his baseball career. He is now a consultant in San Francisco.)
Since the late 1970s Steitz has been
exploring how dna is copied into dna
and then into rna at the molecular
level and how rna makes proteins.
In those early days, however, the
National Institutes of Health offered
little support for structural biology, he
said. Then hhmi stepped in during the
1980s. “hhmi funded five or six structural biology labs in the country. That
helped the whole field because they set
the agenda,” Steitz said.
By 1995 Steitz had turned to what
Levin called “one of the most challenging and difficult problems in molecular science,” namely the structure of
the ribosome’s large subunit. Steitz’s
tool was X-ray crystallography, but in
the early stages of the research, it was
hard to form a high-quality crystal of
the ribosome. Once a suitable crystal

et cetera • • •
CO L L I N S N A M E D TO L E A D N I H

was achieved, the next step was to
beam X-rays through it to plot a diffraction pattern that would reveal the
ribosome’s atomic structure. In 2000
Steitz and his team used a 2.5 billion
electron volt X-ray beam at Brookhaven
National Laboratory’s National
Synchrotron Light Source.
“It was the most exhilarating moment
I have had in science, to peer into the
inner workings of the ribosome and think
about how it works,” Steitz said. “It was
like trying to climb Mount Everest. We
knew it was doable in principle but we
didn’t know if we would ever get there.”
Although the prizewinning research
began as a quest to find out how a complex molecular structure works, it has
since yielded clinical applications. By
blocking ribosomal activity in bacteria,
many antibiotics cure diseases caused
by bacterial infection. No organism can
live, Steitz said, “without a machine that
makes proteins.”
The company that Steitz co-founded
in 2001, Rib-X Pharmaceuticals, has
applied the insights obtained from
the ribosome-antibiotic structures to
develop new antibiotics that can be used
to treat such multi-antibiotic resistant
infections as mrsa. The company is
developing both oral and intravenous
drugs for treating skin infections,
pneumonia, bronchitis, and soft tissue
infections. One compound developed by
the company has successfully completed
phase 2 clinical trials.
—John Curtis

Online: Yale Netcasts
• Thomas Steitz: Mapping the Ribosome
• Nobel lecture and awards ceremony

Francis S. Collins, m.d., ph.d. ’72, fw ’84, was
appointed head of the National Institutes of
Health (nih) in August, and in October was
named one of nine recipients of the National
Medal of Science.
Collins is best known for leading the
Human Genome Project and for his discoveries of disease genes. In June 2000 a draft of
the human genome was announced and an
initial analysis was published in 2001.
The National Medal of Science was created in 1959 and is administered for the White
House by the National Science Foundation.
Awarded annually, the medal recognizes individuals who have made outstanding contributions to science and engineering. The medal,
along with the Medal of Technology, is among
the highest federal government honor given
to scientists, engineers, and inventors. Collins
and the other honorees received their awards
from President Barack Obama at a White
House ceremony in October.
—John Curtis
YA L E I N G L O B A L H E A LT H CO N S O R T I U M

Yale has joined five universities and the
Association of University Technology Managers
(autm) to spur the dissemination of technology and medicines to the developing world.
In a statement released in November,
Harvard, Yale, Brown, Boston University, the
University of Pennsylvania, Oregon Health &
Science University, and autm said they will try
to ensure that their intellectual property rights
do not block access to drugs, vaccines, devices,
and medical technologies in developing countries. They also agreed to try to develop licensing strategies that promote global access to
health technologies, to control patent rights so
as to make lifesaving products available in the
developing world, and to support the development of health-related technologies aimed at
diseases prevalent in the developing world.
“We believe the principles and strategies
enunciated in this document will further our
shared goal of providing access to the benefits
of our medical inventions for the most needy
global citizens,” said Yale President Richard
C. Levin.
—J.C.
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Yale mourns the loss of
a gifted student and
compassionate friend

t o p Annie Le, a promising graduate student
in pharmacology and the child of Vietnamese
immigrants, was murdered in a laboratory on the
medical campus in September.

yale medicine winter 2010

a b o v e On September 14, the day after police
found Annie Le’s body hidden inside a wall at 10
Amistad Street, members of the Yale community
gathered for a vigil at Cross Campus.

Annie Le was a talented scientist, a caring friend, a helpful lab mate, and a
fashionista whose click-clacking high
heels signaled her arrival from afar. Her
friends, classmates, and teachers remembered what her advisor called “Annieisms”—her fondness for fried chicken,
her perfectly accessorized wardrobe, and
her insistence on wearing a skirt even
while doing messy lab experiments.
Scores of people touched by her full
and all-too-short life gathered in Battell
Chapel in October to honor Le, a 24-yearold graduate student in pharmacology
who had been killed in a Yale laboratory
a month earlier. A laboratory technician
had been charged with murder in the
case and is being held on $3 million bail.
President Richard C. Levin described
Le as “so emblematic of the kind of student Yale wishes to educate and send out
into the world, a model student for the
Yale of the 21st century.” The child of
Vietnamese immigrants, Le grew up in
central California, was a standout high
school student who garnered $160,000
in college scholarships, won a prestigious
nih fellowship while an undergraduate
at the University of Rochester, and at
Yale won a fellowship from the National
Science Foundation.
Working in the laboratory of Anton
M. Bennett, ph.d., associate professor
of pharmacology, Le studied how some
fatty acids regulate an enzyme believed to
be involved in cellular metabolism. She
wanted to find out whether the enzyme
is linked to metabolic disease. “She was
happy with her life, happy with herself,
and happy with her dreams,” Bennett

said. “That’s why Annie was always smiling.” Her work contributed to a research
paper that will soon be published in the
Journal of Clinical of Investigation and will
be dedicated to her memory.
“Annie valued science precisely
because she saw in it a moral purpose,”
said Jon Butler, ph.d., dean of the
Graduate School of Arts and Sciences.
“She hoped that her research would stem
the onset of metabolic disease.”
Friends also recalled Le’s lighter side.
“I don’t know anyone else who could
wear five-inch heels while doing laborious mouse surgery, eat fried chicken
and not gain an ounce, and use smiley
faces in her presentations and not lose
the respect of her audience,” said fellow
graduate student Tara Bancroft.
Le’s roommate reported her missing on the night of September 8. Five
days later, the day she was to have been
married to her college sweetheart, police
found her body in a crawl space behind
a wall in the basement of a building at
10 Amistad Street, where Le had gone
to check on her research mice. Police
arrested Raymond Clark III, a lab technician who worked in the building, on
September 17. Clark had not entered a
plea at press time.
—John Curtis
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For the first time, dna
sequencing leads to
diagnosis and treatment
A Turkish boy suffering from dehydration and failure to thrive became
the first patient to receive an accurate
diagnosis and successful treatment
based on the complete sequencing of
his protein-coding genes, thanks to the
work of Yale researchers.
A team led by Richard P. Lifton, m.d.,
ph.d., chair and Sterling Professor
of Genetics and professor of internal
medicine, used emerging genomics
technologies to identify an unexpected
and rare genetic mutation in the infant,
who had previously defied diagnosis.
That information allowed the baby’s
doctors to embark on a successful treatment program.
The milestone achievement resulted
from a new approach to dna sequencing known as whole-exome sequencing.
This approach zooms in on the 1 to 2
percent of the genome that carries protein coding information, where diseasecausing mutations are most likely to
occur. Lifton and colleagues at the Yale
Center for Genome Analysis—including
Murim Choi, ph.d., a postdoctoral fellow, and Shrikant M. Mane, ph.d., director of the genome analysis center at West
Campus—worked out a method that
combines gene chip technology to purify
the target dna along with the latest
high-throughput sequencing techniques
to decode it. Their approach yields a
comprehensive view of an individual’s
protein-coding genes for a few thousand
dollars—10 to 20 times less costly than
sequencing the entire genome.
At the request of a Turkish doctor,
the Yale group deployed the technology to investigate the five-month-old
baby, who was suspected of having a
rare genetic kidney disease known as
Bartter syndrome, marked by excessive
urination. The baby’s dna arrived at
Yale, and in just ten days, the researchers had their answer. The kidney gene
was fine; however, the baby turned out
to have an unsuspected mutation in a

protein responsible for water and salt
absorption in the intestines. That defect
led to chronic chloride diarrhea, which
in turn caused the child’s dehydration.
Armed with that information, Lifton
and colleagues then went back to other
infants with similar symptoms attributed to Bartter syndrome, and identified five more with mutations in the
intestinal transporter.
The results, reported in the
Proceedings of the National Academy of
Sciences in October, show that the new
technology can quickly generate clinically useful results, bringing doctors
and patients closer to the day when comprehensive sequencing information will
be a routine part of medical care.
“We believe this heralds the dawn
of a new era in genetics and personalized medicine,” said Lifton, who is also
an investigator for the Howard Hughes
Medical Institute. “As the cost of dna
sequencing continues to plummet, it
seems clear that this technology will be
useful for clinical diagnosis in a number of settings.”
—Pat McCaffrey

et cetera • • •
N E W ST R AT E G Y F O R SW I N E F L U

A Yale researcher has proposed a swine flu
vaccination strategy that would minimize
cases and mortality and reduce costs. The
strategy gives priority for vaccinations to
those most likely to transmit swine flu rather
than to those most vulnerable to the disease.
The Centers for Disease Control and
Prevention and the Advisory Committee on
Immunization Practices (acip) currently recommend targeting such high-risk groups as
children under five; adults 65 or older; and
pregnant women. In a paper published online
in the August 20 issue of the journal Science,
Alison P. Galvani, ph.d., associate professor
of epidemiology (microbial diseases), and
Jan Medlock, ph.d., an assistant professor of
mathematical sciences at Clemson University,
said that vaccinating schoolchildren and their
parents would be more effective.
acip’s vaccination policies, the study
found, would result in 1.3 million infections,
2,600 deaths, and $2.8 billion in economic
impact. Galvani’s model, however, projected
113,000 infections, 242 deaths, and a cost of
$1.6 billion.
—J.C.
H OW H U N G E R B L O C K S F E R T I L I T Y

A molecule that may play a key role in obesity, drug addiction, and depression also
turns off the reproductive system in times
of severe hunger, according to Yale scientists.
In a report in September in the Proceedings
of the National Academy of Sciences, the
researchers identified the molecule as
melanin-concentrating hormone (mch), a
peptide that is made by the hypothalamus.
“Brain neurons that make mch are quiet
most of the time, but when the body is in negative energy balance, mch neurons become
active and can shut down brain neurons that
control reproduction,” said Meenakshi Alreja,

ph.d., senior author of the paper and associ-

ate professor of psychiatry and neurobiology.
—J.C.

Online: Yale Netcasts
Richard Lifton: Genes:
You Are What You Inherit
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Every Patient Tells a Story: Medical
Mysteries and the Art of Diagnosis

yale medicine winter 2010

In her new book, Lisa Sanders examines the state
of diagnostic skills.
The chances are good that you already know the work of
Lisa Sanders, M.D. ’97, HS ’00, assistant clinical professor of
medicine: she writes the monthly “Diagnosis” column in the
New York Times Magazine. Or maybe you’ve seen House, the
Emmy-winning, oddly addictive, not-quite-believable hospital
melodrama for which Sanders is
a consultant. Now Sanders has
written a book that combines the
medical sleuthing of “Diagnosis”
and House with an examination
of the state of diagnostic skills
among contemporary physicians.
The book also provides “insider”
pleasures for those familiar with
the School of Medicine or YaleNew Haven Hospital: Many of
the names of the physicians who
unravel these medical mysterEvery Patient Tells a Story:
ies are familiar, from Nancy
Medical Mysteries and the
Art of Diagnosis
Angoff to Majid Sadigh, from Eric
by Lisa Sanders, m.d. ’97,
Holmboe to Frank Bia.
hs ’00, assistant clinical
With each story of a difficult
professor of medicine
diagnosis,
Sanders expands
(Broadway Books)
on the issues that made it so.
Recurrent chest pain and weakness in a young man. A heart
attack? It turns out to be pernicious anemia. A woman with
long-term weakness and joint pain. “Chronic” Lyme disease?
No—polymyalgia rheumatica.
Sanders argues that physical examination is poorly taught,
both in medical school and during residency. “See one,
do one, teach one” doesn’t suffice for the complex skills of
hands-on examination.
She ends with a moving story of the search for the cause
of her own sister’s death at 42.
—Cathy Shufro

Comparative Studies and the
Politics of Modern Medical Care
edited by Theodore R. Marmor,
ph.d., professor emeritus of public
policy and political science at Yale;
Richard Freeman, ph.d.; and Kieke
G.H. Okma, ph.d. (Yale University
Press) The editors of this volume
have compiled essays covering
health care policy debates and
reforms in Canada, Germany, the
Netherlands, the United Kingdom,
and the United States. The book
explores such issues as primary
care, hospital care, long-term care,
pharmaceutical policy, and private
health insurance.
Handbook of Pediatric Chronic
Pain: Current Science and
Integrative Practice
by Brenda C. McClain, m.d.,
associate professor of anesthesiology; and Santhanam Suresh, m.d.
(Springer) The book addresses
concerns unique to pediatric
pain management, including the
history of pediatric chronic pain;
the advancement of pediatric
pain management as a clinical
subspecialty; the characterization of common pain syndromes;
and the assessment of specific
pediatric and adolescent pain
syndromes. It also discusses such
interventional techniques as
therapeutic blocks, implantable
systems, physical therapy, and
complementary therapies.
Plastic Surgery: Indications and
Practice
by John A. Persing, m.d., professor
of surgery (plastic) and neurosurgery; Bahman Guyuron, m.d.; Elof
Eriksson, m.d., ph.d.; Kevin C.
Chung, m.d.; Joseph Disa, m.d.;
Arun Gosain, m.d.; Brian M.
Kinney, m.d.; and J. Peter Rubin,
m.d. (Saunders) This two-volume
reference work covers all aspects
of aesthetic and reconstructive

plastic surgery practice, with an
emphasis on today’s techniques.
The book’s content and format
follow the core curriculum designed by the academic chairs of
plastic surgery, making it a practical resource for residents and an
ideal review for the plastic surgery
board examination. A bonus dvd
is included with the book.
Transplant
by John A. Elefteriades, m.d. ’76,
hs ’83, the William W.L. Glenn
Professor of Surgery (cardiac) (Robot Binaries & Press) This medical
thriller has cutting-edge technology, seduction, and coercion as
well as questions about the ethics
of modern medicine.
Mother’s Milk
by Charles Atkins, m.d., lecturer
in psychiatry (Severn House Publishers) A forensic psychiatrist
tries to solve the mystery of two
dead teenagers and a missing
homeless schizophrenic while
under pressure from her boss.
Genetics and Medicine in Great
Britain 1600 to 1939
by Alan R. Rushton, m.d., ph.d.,
hs ’80 (Trafford Publishing) This
historical study examines the
close professional relationship
between British scientists studying the nature of heredity and the
practicing physicians of the day.
It shows the close collaboration
between scientists and physicians
during the decades before World
War II that has defined the present understanding of the scope of
modern “medical” genetics.
Anesthesiology Keywords Review
by Raj K. Modak, m.d., assistant
professor of anesthesiology (Lippincott Williams & Wilkins) This
review book is based on the
keyword list distributed to

on campus

residency program directors each
year. Each entry begins with a
keyword followed by a list of key
points and a one- or two-page
discussion. Entries cover all areas
of anesthesiology.
Preoperative Medical Consultation, An Issue of Medical Clinics
by Lee A. Fleisher, m.d.; and Stanley H. Rosenbaum, m.d., professor
of anesthesiology, medicine, and
surgery (trauma) (Saunders) This
volume provides recommendations on ways to handle preoperative consultation and preparation
as well as perioperative management of surgical patients. It
covers the following situations:
emergency and urgent surgery;
perioperative management of
the ambulatory surgery patient;
perioperative anticoagulation
management; hematological
problems in the preoperative
patient; obesity, the metabolic
syndrome, and the surgical
patient; and noncardiac surgery in
the patient with heart disease.
Pediatric Bioethics
by Geoffrey Miller, m.b.ch.b.,
professor of pediatrics (neurology) and neurology (Cambridge
University Press) This volume
offers a theoretical and practical overview of the ethics of
pediatric medicine. It serves as
a handbook and resource for
pediatricians, nurses, residents in
training, graduate students, and
practitioners of ethics and health
care policy. Written by a team of
experts, this book addresses the
difficult ethical questions concerning the clinical and academic
practice of pediatrics.
DeVita, Hellman, and Rosenberg’s Cancer: Principles &
Practice of Oncology, 8th ed.
by Vincent T. DeVita Jr., m.d., Amy

and Joseph Perella Professor of
Medicine and professor of epidemiology; Theodore S. Lawrence,
m.d., ph.d.; Steven A. Rosenberg,
m.d., ph.d.; Ronald A. DePinho,
m.d.; and Robert A. Weinberg,
ph.d. (Lippincott Williams &
Wilkins) The text provides information on the science of oncology
and multimodality treatments of
every cancer type. To ensure a balanced multidisciplinary approach,
each major treatment chapter
is co-authored by a surgeon, a
medical oncologist, and a radiation oncologist. Treatment of each
cancer type is discussed by stage,
with coordinated guidelines on the
role of each treatment modality at
each stage. Consideration is also
given to cancer prevention, screening, palliative care, supportive oncology, and quality-of-life issues.

mif: Most Interesting Factor
by Richard Bucala, m.d., ph.d.,
professor of medicine (rheumatology), pathology, and epidemiology
(microbial diseases) (World Scientific Publishing Company) This
book describes the biology of the
mif (migration inhibitory factor)
gene. Human genetic studies have
identified allelic forms of the mif
gene, and high-expression alleles
have been associated with rheumatoid arthritis, asthma severity,
sarcoidosis, atopy, inflammatory
bowel disease, and other inflammatory and infectious maladies.
The book also discusses the role
of the mif factor itself as a therapeutic target.
The descriptions above are based
on information from the publishers.

send notices of new books to
Cheryl Violante, Yale Medicine,
300 George Street, Suite 773,
New Haven, CT 06511, or via e-mail
to cheryl.violante@yale.edu
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When both food and a sexy
starlet appear in a television commercial, pizza stirs up more brain
activity, but increased stimulation
from either doesn’t necessarily
boost sales.
Ads trigger a battle within
the brain, said Joshua Freedman,
m.d. ’88, associate clinical professor at the ucla Jane & Terry
Semel Institute for Neuroscience
and Human Behavior. He conducted fmri studies on subjects
watching Pizza Hut commercials
and found that shots of food
“dominate” despite scenes of the
scantily clad Jessica Simpson.
“Food tends to produce lots of
activity in different parts of the
brain,” Freedman told an audience at the Rudd Center for Food
Policy and Obesity in October.
The orbitofrontal portion of the
prefrontal cortex typically associated with emotional connection
may light up; however, the insula,
which produces the sensation of
disgust (perhaps at the idea that
pizza is fattening), is also activated. “The battle is drawn, but it is
unclear which region of the brain
will win out,” Freedman said.
Advertisers know how to get
attention, but there is bad attention as well as good, he said. “At
the very least, if they saw these
results they’d probably stop paying for expensive models.”
—John Dillon

The key to healing men often lies
in studying women first, according to a Yale expert who said that
females respond differently not
only to many diseases but also to
therapies designed with males
in mind.
“Go to the more challenging
environment,” Saralyn Mark, m.d.,
associate professor (adjunct)
of medicine and of obstetrics,
gynecology, and reproductive
sciences, urged at a talk in
October sponsored by Women’s
Health Research at Yale. “It’s
kind of the reverse of what happened in the past, when men
were the gold standard.”
Sexual differences in disease
and therapy go beyond disparities
in reproductive systems and size,
said Mark. Most autoimmune
diseases, for example, are more
prevalent in females. Women
may be more resistant to infection from swine flu but are harder
hit when infected, especially
while pregnant. Stem cells graft
differently—female cells match
best with female recipients, while
male recipients of male cells fare
the worst. Recognizing these differences could improve development of novel therapeutics.
“There have been significant
advancements in the field of sexand gender-based research, but
it will require the development
of public/private partnerships to
translate research findings into
improved clinical care for both
men and women,” Mark said.
—J.D.

When pizza and a starlet
compete for attention

Accounting for sex
differences in medicine
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The colonies’ first medical degree
A London surgeon and physician sought a Yale degree
as part of his quest for upward mobility.

yale medicine winter 2010

By Kerry Falvey
In 1723 Yale granted the first medical
degree issued in the American colonies
to Daniel Turner (1667–1741), a London
surgeon-turned-physician who had neither attended Yale College nor even set
foot in North America. Moreover, Yale
would not have a medical school for
nearly another century.
The story has been extensively documented by Philip K. Wilson, ph.d.,
of the Penn State University College
of Medicine, and much of this account
is based on his work. It begins with a
parcel of 25 books that Turner shipped
across the Atlantic in September 1722
as a gift to Yale. He was not the typical gentleman benefactor. In truth,
Turner was not even a gentleman by
the standards of 18th-century Britain.
Born a tradesman’s son, Turner was a
surgeon—an occupation then considered akin to manual labor. Medicine,
known as “physic,” was the domain of
university-educated gentlemen.
Turner had been admitted into the
Barber-Surgeons Company in 1700
after a seven-year apprenticeship.
Seeking upward mobility, he expressed
his ambition by becoming an author.
Four of his case histories were published in the Philosophical Transactions
of the Royal Society of London—an
unusual feat for a surgeon. He produced other works, including Apologia
Chyrurgica: A Vindication of the Noble
Art of Surgery.

In 1711, Turner paid a fine of £50 to
be released from the Barber–Surgeons’
Company and was licensed to practice physic by the Royal College of
Physicians. Although he hoped to
become a fellow of the Royal Society,
Britain’s elite club of natural philosophers, scientists, and physicians, Turner
lacked the personal connections, social
status, university education, or recognition as a scholar that might have gained
him entry. Instead of buying a medical
degree from a Scottish university—
a common practice at the time—he
politely asked Yale to send him one.
In a letter written in Latin and
addressed to the “Most Erudite Lords”
of “Yale Academy,” Turner conveyed
his desire to supplement the “infantile
state” of Yale’s library by donating 25
books from his personal collection.
He saved his request for a postscript:
“If Your Lordships judge me worthy
of the Degree of Doctor of the Yale
Academy, and care to transmit to me a
Diploma, I shall accept it not only as a
token of Your Gratitude, but shall consider it an honor as great as if it had
been conferred by another, even more
renowned University.”
Despite the backhanded compliment,
Yale awarded the honorary M.D. in absentia in 1723. It remains unclear why the
august members of the Yale Corporation
bestowed the degree on Turner, although
he had been recommended to them by

Jeremiah Dummer, the Connecticut
Colony’s agent in London.
Yale had been seeking donations of
books for its nascent library since its
early years, and most of those donations
came through Dummer. By 1718 Yale’s
library consisted of more than 1,300
volumes, many donated by such leading
intellects as Sir Isaac Newton.
Turner’s efforts to have his honorary degree recognized by the Royal
College of Physicians were in vain. But
he accepted the doctorate as a symbol of
his erudition and medical knowledge,
his recognition as an accomplished
author, and his ability to contribute to
an institution of learning. Thereafter,
according to Wilson, he signed himself
“Daniel Turner, M.D., of the College of
Physicians in London.”
Yale was no diploma mill and Turner
was no quack, yet the incident underscores how far medicine—especially
medicine at Yale—has come in nearly
300 years. What in the 18th century was
a largely unscientific occupation has
become a profession requiring rigorous training and exacting standards for
licensure. What was once the “Collegiate
School” in Connecticut has become one
of the world’s leaders in medical education, patient care, and research.
This article has been excerpted and adapted from
a forthcoming book by Kerry Falvey celebrating
the bicentennial of the Yale School of Medicine
(yalebooks.com/ysm200).
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john curtis

b e l o w Yale University owes its name to the
donor of a collection of books for the fledgling
school in 1701, and it has accepted such donations ever since. Turner’s offer of 25 books arrived
in 1722, but the medical school library was not
formalized until 1941 when three faculty members
contributed their own extensive collections of
medical literature.

a b o v e The letter sent by Daniel Turner in
September 1722 seeking a medical degree. The
letter was translated from Latin by C. Nockel
Fabbri and first published in A History of Yale’s
School of Medicine by Gerard N. Burrow.
l e f t A portrait of Daniel Turner by Johann
Faber the Younger, 1734. This mezzotint depicts
Turner as a learned scholar: all the trappings
of gentility are apparent, including Turner’s
lavish apparel, luxurious wig, and his extensive
collection of books.
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clockwise from top :
Visitors entering from Park Street
come in through an atrium that
includes a player piano and a
waterfall.
A detail from a mural in the atrium.
A rooftop garden on the seventh
floor, which includes plantings and
a stream, is designed as a meditative space for patients.
A waiting room at Smilow lacks a
television but features an aquarium
with exotic fish. A television, the
hospital’s planners believe, sends a
message that patients are in for a
long wait.
A detail from a mural in the atrium.
The hospital from Park Street.
Operating rooms were designed
with all equipment hanging from
the ceiling, making it easier for
physicians, nurses, and technicians
to move around and easier to clean.
“What do I have to do to practice
here?” ask new surgery recruits.
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The Smilow Cancer Hospital at
Yale-New Haven is built around
a new philosophy of patient care.
By Colleen Shaddox
Photographs by Michael Marsland
Ask to see the televisions in waiting rooms at the new Smilow
Cancer Hospital at Yale-New Haven if you want to delight Abe
Lopman, m.b.a., its executive director. He’ll smile triumphantly
and proclaim that there aren’t any. “It always sends a message that you’re going to be waiting for a while,” he explained.
Other cancer centers have found tropical fish to be much more
popular with patients, so several patient waiting areas in the
new hospital feature saltwater tanks the size of loveseats. Exotic
fish create serpentine ribbons of color—a markedly different
sensory experience from those of Judge Judy or Rachael Ray as
people wait to be called for an appointment.
“You feel cared for and nurtured here,” said Thomas J.
Lynch Jr., m.d. ’86, director of Yale Cancer Center (ycc) and
Smilow’s physician in chief. That feeling is engendered by
everything from the artwork in the lobby to the trees and a
stream in a rooftop garden.
It’s a small thing, this preference for fish over televisions. But it’s indicative of a larger principle: cancer care
should focus on what the patient needs and wants. It should
be personal. At 14 stories and 500,000 square feet, Yale-New
Haven’s new cancer hospital cost an estimated $467 million.
Every floor boasts an arsenal of leading-edge technology. Yet
that simple core principle of patient care is the new facility’s
true cornerstone. The ideal of personal cancer care shows in
amenities intended to bring comfort to patients as well as
in the building’s very structure, designed to change the way
medicine is practiced.
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Making cancer personal
right

Benefactor Joel Smilow.

fa r r i g h t Maria Menocal
was the hospital’s first outpatient
in October.

Bringing cancer teams together

Cancer care is by nature interdisciplinary; however, the physical distance between departments often made consultation a
challenge. The traditional arrangement had physicians grouped
by specialty, and patients traveled from the surgeon to the radiologist to the oncologist and hoped that their medical charts
arrived ahead of them. Clinicians recognized that they needed
to work collaboratively but often resorted to faxes and e-mails to
do so. “It’s always more difficult when the team members are
not in one place and living and breathing these cases together,”
said Edward Chu, m.d., professor of medicine (medical oncology), and of pharmacology, and deputy director of ycc.
Now the patient will literally be at the center of care, with
various disciplines housed together in suites that facilitate collaboration. The suites will be organized by the type of cancer treated
there, and a multispecialty team is now mobilized to treat each
patient. Before Smilow, cancer patients at Yale needed to visit as
many as six different buildings to get their care, recalled Chu. It
was inconvenient for patients—doubly so for the elderly or those
exhausted from their treatments, he said.
The new building is designed to foster collaboration
in New Haven and beyond, said Robert Udelsman, m.d.,
m.b.a., chair and the William H. Carmalt Professor of
Surgery. Teams will have access to conference rooms where
they can look at diagnostic-quality images on large screens
and interact with specialists at distant sites. Prognoses are
more favorable for patients whose treatment is overseen by
physicians with specific expertise and access to the best scientific data, said Udelsman.
Smilow is also designed to accommodate patients who
must travel to get their cancer care at the medical center.
Nearby 2 Howe Street, also constructed as part of the project,
will feature residential units for patients and their families.
“We want to be a destination hospital,” said Udelsman.
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Waterfalls, fish, music, and coffee

The building had its grand opening on October 21, when donor
Joel Smilow, a Yale College alumnus and the building’s namesake, and his wife, Joan, were honored. The first therapeutic
radiology patient was seen a few days later. Other operations
will be moving into the building in carefully choreographed
stages through the spring.
Patients typically enter for their first visit through
the front door into a bright soaring space with a two-story

waterfall, a café, a piano, and a large reception desk with staff
who can look up a patient’s schedule for the day and offer
directions. Patients can also enter through 55 Park Street,
which is connected to the Air Rights Garage. The building has
a walkway that leads directly to Smilow’s fourth floor. Yale-New
Haven Hospital’s laboratories will be housed in 55 Park, constructed as part of the project.
Reserved parking is available by the front door for
patients in therapeutic radiology who must visit daily during
treatment. They’ll get treatment in the basement, but they will
still enjoy the natural light that illuminates much of Smilow. A
large skylight opening into the ground floor atrium brightens
the reception area. Glass transoms above doors throughout the
building add to the airy feel. Waiting areas have open spaces as
well as private nooks to accommodate patient preferences. The
cabinetry’s light wood tones create a less institutional look.
This décor is a change from the existing Hunter
Radiation Therapy Center, said Peter M. Glazer, m.d. ’87,
ph.d. ’87, hs ’91, department chair and the Robert E. Hunter
Professor of Therapeutic Radiology. The ambiance of Hunter
is not bad, Glazer said, but Smilow is a definite upgrade aesthetically and practically. “We have very good equipment now
and will have even better equipment at Smilow,” he said. For
example, a Novalis Brainlab system will be installed, allowing
stereotactic treatment—minimally invasive techniques guided
by a three-dimensional coordinate system—for tumors of the
spine and other locations. The move also offers the therapeutic
radiology staff housed there the benefits of being on a single
floor. As the department doubles the number of exam rooms,
Glazer expects better patient flow.
The ground floor is home to the Women’s Cancer Center
for treatment of breast and gynecologic cancers. The center
will also be the site of regular screening mammography. It is
located across from a boutique selling wigs and other items for
patients in treatment. The store will have a “Saks Fifth Avenue”
feel to it, said Lopman.
New space for patients, more space for physicians

Smilow will increase imaging capacity for the Department of
Diagnostic Radiology from five magnetic scanners to eight,
including dedicated mri machines in the Breast Center and in
the operating room for mri-guided surgery. Diagnostic radiology, like many departments involved in Smilow, however, will
not move all its faculty and staff to the new building. “The
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Dean Robert Alpern was among
the speakers at the hospital’s
dedication in October.

logistics are challenging, but Smilow Cancer Hospital represents a wonderful growth opportunity for our department,”
said department Chair James A. Brink, m.d. But he noted that
the radiologists had been practicing at varied locations already.
The improvements offered at Smilow and the additional capacity in a department that sees more patients every year make the
move “something we’re very excited about,” he said.
Smilow’s operating rooms are unusually large. All
equipment is ceiling-mounted and slides into place wherever
the surgical team wants it. This mobility includes drop-down
high-definition screens that allow a surgeon to refer to an
imaging study. The ceiling-based system makes it easier for
the team to move and allows the room to be rapidly cleaned,
explained Lopman. According to Udelsman, when physicians
being recruited to the Department of Surgery tour the new
facility, they ask: “What do I have to do to practice here?”
Children will continue to receive inpatient care at YaleNew Haven Children’s Hospital. A connecting walkway will
give them access to a pediatric floor in Smilow for treatment.

For adults, the hospital offers inpatient rooms, all private. And yes, these rooms have televisions. Private rooms are
better for infection control and make it easier for nurses to
practice, said Lopman. Clinicians will be able to enter information on a bedside computer. The information will be available
to every member of the team immediately. Each room has a
sleeper sofa so that family members can stay overnight, and
visiting hours never end at Smilow. “I’ve always been shocked
by how we divorce the family from the patient at a time when
they need their families more than anyone,” said Lynch.
On the rooftop garden, water features filter out the noise
of the city and make the spot a destination for quiet walks.
The building is equipped with high-speed elevators, but many
stairwells have glass exterior walls to make them an inviting
alternative. “We’re trying to encourage walking,” said Lopman.
It’s an untraditional goal for a cancer center. But then Smilow
doesn’t intend to be a traditional cancer center. “It’s built,” he
said, “to change the patient’s experience.” YM

A new hospital and a
chance to make great
strides against cancer

Thoracic Oncology Center. Lynch led
teams that made discoveries in targeted therapies in lung cancer and
has published widely. He also maintained a clinical practice and hopes
to continue doing so in New Haven.
He is one of the founders of the
Boston-based Kenneth B. Schwartz
Center and now serves as chair of its
board of directors. Lynch pioneered
the Schwartz Center Rounds, in
which multidisciplinary teams discuss the social and emotional issues
that arise in patient care.
His plans for personalized medicine at Yale are linked to the new
West Campus research facility on
the Orange-West Haven border.
The complex, purchased from
Bayer in 2007, gave the university
400,000 square feet of research
space that will include a cancer
biology institute. “It’s Smilow and
West Campus,” said Lynch. “You
can’t do one without the other.”
Lynch foresees a rigorous
program of research to match a
growing list of specific genetic

For Thomas J. Lynch Jr., m.d. ’86,
director of Yale Cancer Center and
physician-in-chief at Smilow Cancer
Hospital at Yale-New Haven, the
new building makes cancer personal
on three levels. It provides “a warm
and comfortable environment for
patients.” The location of specialists
in team suites allows for multidisciplinary, patient-centered care.
But the biggest innovation may be
microscopic. Physicians will be able
to do molecular profiling rapidly—a
rarity even in the most sophisticated
cancer centers. This technology will
allow them to plan treatment suited
to the genetic signature of each
patient’s cancer. Combine that with
information about a patient’s general health and history, and the result
is personalized medicine—a treatment plan for one specific patient.
These therapies hold the
promise of greater effectiveness

in killing cancer cells while reducing the side effects of treatment.
Lynch’s enthusiasm for personalized medicine springs from 25 years
as an oncologist specializing in lung
cancer and his dissatisfaction with
the range of therapies available to
his patients. He deems the past few
decades’ advances in cancer treatment only “modest.” The chance
to make major strides against the
disease through the combination
of top-flight research and clinical
programs is what drew the native
Bostonian back to Yale.
Lynch returned to New Haven
in April 2009 with the goal of making Yale a leader in personalized
medicine in both research and
clinical care. Lynch formerly worked
and taught at Harvard, where he
was a professor of medicine and
chief of hematology/oncology at
Massachusetts General Hospital
(mgh) Cancer Center. He also
directed the Center for Thoracic
Cancers at mgh and was director
of medical oncology at the mgh

Colleen Shaddox is a freelance writer in Hamden, Conn.

signatures with treatments tailored to be effective against them.
This is the best hope, he believes,
for improving outcomes in solid
tumors, the cancers in which
medicine currently has the least
success. The marriage of Smilow
and West Campus promises to take
discoveries from the bench to the
bedside more quickly. The hospital
will have a team devoted to phase 1
clinical trials so that patients get
the most comprehensive support
possible and so that data collection
is enhanced.
“If what we do in 25 years
is practice the same oncology
we’re practicing now, we haven’t
achieved the promise of Smilow,”
said Lynch.
—Colleen Shaddox

Online: Yale Netcasts
Thomas Lynch: The Next Frontier
in Cancer Treatment

Scott Berkowitz took a year off
from a cardiology fellowship at
Johns Hopkins to work on the
Senate Finance Committee under a
training grant to investigate Medicare policy. “It’s been fascinating
to see the political dynamics, and
to realize that this is the center of
the next generation of health care,”
he says.

paul fetters
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From Cedar Street
to Capitol Hill

Some med school alumni effect change not one-on-one,
but through health policy, and on a grand scale.

By Jenny Blair
Brenda M. Ritson, m.d. ’06, was only a few weeks into her fellowship in Washington, d.c., in the early spring of 2005 when
Sen. Hillary Rodham Clinton invited her into her office.
“Come up with a progressive alternative to hard-cap tort
reform,” the New York Democrat told her. “Here’s my Rolodex.
You have three months.”
“I started sweating,” Ritson recalled. “I called my mom.
And then I got down to business.”
Ritson was working in Clinton’s office as a fellow of the
Women’s Research and Education Institute, an independent
nonprofit organization, after her third year in medical school.
After Clinton’s challenge, Ritson spent weeks educating herself at the Library of Congress and on the Internet. Eventually
she chanced upon an article about a hospital in Michigan that
had decided to apologize to patients who had been harmed
by medical errors. By avoiding lawsuits the hospital was able
to save millions of dollars, and used the money to hire more
physicians and invest in innovative patient safety systems.
Intrigued, Ritson met the hospital’s ceo and shaped the idea
into a national proposal. Clinton, along with then-Sen. Barack
Obama, introduced the idea as part of a bill in Congress in
September 2005, calling it medic, for National Medical Error
Disclosure and Compensation. Though the bill “died in committee,” Ritson said, the concept continues to pop up in new
bills; a New England Journal of Medicine article; and the Sorry
Works! Coalition, an advocacy group that urges full disclosure,
apologies (when appropriate), and compensation (when necessary) following adverse medical events. And the concept of
apologizing for medical errors is catching on among hospitals,
including Yale-New Haven Hospital, which began a similar
program last year. “It makes me proud to know that my ideas

have somehow contributed to or influenced a discussion of a
very challenging problem, and it excites me to watch the ideas
grow and evolve,” says Ritson, now a practicing pediatrician.
Making a career in health policy

Ritson’s turn at working with lawmakers is something of a
tradition among Yale physicians, many of whom have applied
their medical training and experience to public policy. For some
it is a sideline. But others hang up their stethoscopes and make
policy a full-time career. A doctor’s journey into government
often starts with an epiphany. One saw the light in the Amazon
rain forest, another took up a challenge to go to Washington,
and a third grew frustrated by the prevalence of preventable ailments. But what they all have in common is an interest in helping many people at once and a willingness to pursue their goals
over years, if not decades. They often work behind the scenes,
rarely getting credit for their achievements. Some work in government, others in advocacy groups, and some in academia. But
all moved from treating people one on one to treating the public
at large. They are among many alumni who choose careers
beyond the clinic or the laboratory and find innovative and
sometimes unusual ways to promote health.
William L. Kissick, m.d. ’57, m.p.h. ’59, dr.ph. ’61,
developed an interest in public health during medical school
while accompanying his wife, Priscilla, a nurse with the
Visiting Nurse Association, on home visits. “There was a
certain clash of cultures,” he said, recalling that her patients
would often refuse to go to the hospital because they viewed
it as a place to die. Later, as one of the first residents in a
unique social medicine program at Montefiore Hospital in
the Bronx, he decided that he wanted to rebuild the American
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From Cedar Street to Capitol Hill

The policy makers
Scott A. Berkowitz, m.d. ’03, m.b.a. ’03
Fellow on the Senate Finance Committee
Larry C. Horowitz, m.d. ’69
Chief of staff and personal physician to the late Sen. Edward
M. Kennedy
William L. Kissick, m.d. ’57, m.p.h. ’59, dr.ph. ’61
Member of the 11-person task force that developed Medicare
Howard K. Koh, m.d. ’77, m.p.h.
Assistant secretary for health in the U.S. Department of Health
and Human Services
Donald O. Lyman, m.d. ’68
Chief of California’s Division of Chronic Disease and Injury Control
and architect of statewide anti-tobacco campaign
Brenda M. Ritson, m.d. ’06
Fellow in the office of then-Sen. Hillary Rodham Clinton and the
Women’s Research and Education Institute, 2005

Are you working in health care policy or another of the fields we’ll
be profiling in our “Alumni Career Paths” series? Do you know medical school alumni, former Yale house staff, or fellows who are?
Send us the names and then check the Web edition of Yale Medicine to
view an expanding list of alumni with similar interests. You can write
to us at ymm@yale.edu and view the list at yalemedicine.yale.edu.
“Alumni Career Paths” future articles:
• International health and research
• The front lines of clinical practice
• Military medicine
• Biotech, pharma, and business
• Academic medicine
• Physician/writers

medical system from the ground up. William H. Stewart,
m.d., who would serve as surgeon general from 1965 to 1969,
heard Kissick express his ambition at a public health conference in Detroit in 1963, and asked, “Why don’t you come to
Washington and learn something first?” Kissick was soon
assigned to the 11-person task force that developed Medicare.
He spent seven years in Washington, contributing to some 13
legislative efforts in health policy including Medicare, which
became law in 1965.
Working with the underserved during medical school
helped turn Larry C. Horowitz, m.d. ’69, toward policy-making,
a career that later brought him national prominence as chief
of staff and personal physician to the late Sen. Edward M.
Kennedy, the Massachusetts Democrat. In medical school
Horowitz was inspired by such mentors as then-Dean Fritz
Redlich, m.d., and Yale’s charismatic President Kingman
Brewster Jr. to join the Student Health Project, which assessed
the health needs of the underserved populations in New Haven
and New London, and migrant communities in Riverhead,
Long Island. During Horowitz’s residency the Vietnam War
nudged him into a two-year commitment to the public health
sector as an alternative to the draft. He worked in Washington
at the Health Services and Mental Health Administration, an
umbrella organization that oversaw a number of national health
programs. It was then that he caught the eye of Kennedy, whom
he had invited to give a talk to his co-workers. Horowitz began
that practice in Harkness Dormitory, inviting such luminaries
as author William Styron and Walter and Eugene Rostow, brothers who held posts in Democratic administrations in the 1960s.
After joining Kennedy’s team Horowitz finished his residency
while traveling between Palo Alto, Calif., and Washington as a
Robert Wood Johnson fellow handling the Senate’s oversight of
the pharmaceutical industry. He decided to continue in government, he said, because he loved working on Capitol Hill. He
served as Kennedy’s chief of staff from 1981 until 1986.
“It’s not like I decided, ‘That’s it for clinical medicine,’ ”
said Horowitz, who is now a consultant to pharmaceutical companies and runs an investment and entertainment company of
his own. “It’s just that each step was so exciting and fulfilling
and gave you a sense that you were contributing to something
larger than yourself in a meaningful way. … Working for Sen.
Kennedy was great fun. You had the opportunity to meet all
the best minds that existed in the United States and elsewhere
on the issues you cared about.”
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A passion for prevention

Scott A. Berkowitz, m.d. ’03, m.b.a. ’03, is taking time off from
a cardiology fellowship at Johns Hopkins to spend a year as a
fellow on the Senate Finance Committee. His fellowship is part
of an nih training grant in geriatrics investigating Medicare
policy. “It’s been fascinating to see the political dynamics,
and to realize that this is the center of the next generation of
health care. To do whatever I can, however small, to help in
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Ritson is now a pediatrician in a
practice in Connecticut. She plans
to return to Washington after
gaining clinical experience.

robert lisak

Brenda Ritson spent a year in the
office of then-Sen. Hillary Rodham
Clinton, developing a progressive
alternative to tort reform.

that process has been very rewarding,” he says of his front-row
seat on health care reform. “There are definitely times when
the physician background helps.” During the summer between
his fourth and fifth years of graduate school, he too worked for
Kennedy, and between his first and second years of internal
medicine residency at Johns Hopkins, he worked in the office
of former Illinois Gov. Rod Blagojevich.
Indeed, it is the big picture that pushes many doctors
into policy. It happened to Donald O. Lyman, m.d. ’68, in the
Brazilian Amazon, where he spent a summer as a medical
student working with the Yale Arbovirus Research Unit. He
arrived to find villagers waiting to see “the doctor.” Nervous
at the prospect of treating rare tropical diseases, he nonetheless agreed to see them. The terrible banality of what he saw
changed his career. “After about the 12th patient, I said to
myself, ‘The things I am seeing are no-brainers. Malaria, malnutrition, things like that. You can go into prevention and you
could do a lot more good, both in places like this and at home,
instead of treating people who are sick one-on-one.’ ” Before
long, Lyman had signed on with the Epidemic Intelligence
Service at the Centers for Disease Control. That led him to
full-time public health work in California, where he is chief of
the state’s Division of Chronic Disease and Injury Control and
where he oversaw a statewide anti-tobacco campaign that is
credited with saving tens of thousands of lives.

A passion for prevention also drives Howard K. Koh,

m.d. ’77, m.p.h., who in June became the assistant secretary
for health in the U.S. Department of Health and Human
Services. In that position Koh serves as senior public health
advisor to the secretary and oversees the Office of Public
Health and Science, the Commissioned Corps of the U.S.
Public Health Service, and the Office of the Surgeon General.
(His brother, Harold H. Koh, j.d., former dean of the Yale
Law School, is legal advisor to the U.S. Department of State.)
“I’ve seen too many patients suffer preventable suffering
and die preventable deaths. The only answer to that challenge is promoting prevention through public health.” After
finishing residency, Koh taught cancer prevention and got
his first taste of satisfying policy work in 1992 while heading a coalition that successfully advocated a tobacco tax in
Massachusetts. Later, as that state’s public health commissioner, he guided his state from 10th- to third-healthiest in
the nation, in part because of a high quitting rate among
smokers. Like Horowitz and Kissick, Koh also honed an interest in the needy while at Yale. Though he said his parents
impressed upon their children the importance of both education and service to others, he names the Reverend William
Sloane Coffin Jr., the civil rights leader and Yale chaplain
between 1958 and 1975, as a strong influence. “He always
preached about the broader perspective on life and serving
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From Cedar Street to Capitol Hill

the underserved—caring for those in society who are counted
least and put last,” said Koh of Coffin Jr., who died in 2006.
“I think of him often and miss him tremendously.”
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How to make policy work

“Fresh-faced shiny kids” in their late 20s and early 30s—which
might describe the speaker herself—are the people doing
much of the work in Washington, d.c., said Ritson. Many
arrive with little or no experience in the jobs they’re about
to undertake. No one taught Ritson how to research a policy
proposal; she was expected to figure it out herself. The system
seeks the self-motivated and the adaptable.
For example, after a surgical internship and a lab research
year, Michael D. Miller, m.d. ’86, wound up dissecting the
federal budget. Seeking to work in health care at the “ultimate
macro level” after leaving an orthopaedics residency, he entered
the policy arena as a fellow with the American Association
for the Advancement of Science (aaas). He worked on funding for biomedical research at the Office of Management and
Budget—a plum location where no aaas fellows had landed
before. There, he says, he got a bird’s-eye view of the entire federal government by studying the flow of funds. “It’s crucial to
understand how money flows,” he said. “I was—and still am—
astounded by the number of people at senior levels who don’t
understand the budget process.”
The relationship between money and policy is complex
and not always healthy. Policy, Lyman believes, should drive
funding. “You start with the policy; you start with the social
justice, and the dollars follow.” But sometimes money appears
to lead. “There were a number of legislative hearings when the
advocates thought they had the votes,” Lyman said. “In comes
the Assembly speaker and he walks around the room and he
talks to each and every member of the legislative committee
individually, and they either turn red with rage or they walk
out. Then they vote down the bill. The advocates lament that
they could just hear tobacco money passing hands.”
For Lyman, the words he uses are as important as
money. He credits the Hollywood advertising industry for the
success of the phrase “secondhand smoke” during his antitobacco campaign. And he is careful to make his public health
messages culturally appropriate. But the fading prominence of
the phrase “social justice,” a concept that underlies everything
he does, saddens him.
“It is just astounding that the vocabulary, the metaphors,
the mindset are very geared to money,” he said. “What happened to social justice? What happened to the quality of care?
What happened to outcomes?”
Keeping a hand in medicine

In 1969, Kissick left Washington for the Wharton School of
the University of Pennsylvania, where he taught for decades
and helped found several combined-degree programs. He is
now adjunct professor of political science at Yale, and teaches

undergraduates about the evolution of American health care
policy. He is decidedly skeptical about current health care proposals. “I’ve been in the racket for a half-century,” he said, “and
I’ve learned just about everything that won’t work.”
Despite those years spent crafting and teaching policy,
Kissick’s heart has always remained in medicine. His last
clinical experience was in 1963, when he was called to a home
delivery at 3 a.m. during a snowstorm. But his identity as a physician is tenacious. Although a great many lawyers who pass
the bar never practice law, said Kissick, “when you go to medical school, you’re hooked. You can’t get out.”
Berkowitz, who plans to pursue clinical cardiology alongside a policy career, believes that medicine opens more doors
to more career paths than it did in the past. “I think it’s really
important for people going in and starting medical school to
recognize that the opportunities with a medical degree, both
in terms of taking care of patients and impacting policy on a
broader level, are really great and really exciting,” he said.
Koh, who is board-certified in four specialties, practiced
clinical medicine for more than 30 years until his Washington
post began. But he is thrilled to be on the front lines of policy,
and relishes the interdisciplinary nature of his job. “I really
enjoy it when the worlds of medicine and law and business and
community and advocacy all interconnect in the form of public
health,” he said.
Ritson is building up clinical pediatric experience and
plans to return to Washington within a few years. Miller did
volunteer clinical work but spent the bulk of his time outside
the hospital. After working with the nih on hiv/aids policy,
he joined the team of Rep. Sander M. Levin of Michigan, where
he worked on Medicare a generation after Kissick. He also
worked with then-First Lady Hillary Rodham Clinton’s health
care task force in its first incarnation in the 1990s. Miller now
blogs and runs a consulting company. And Horowitz, though
he later played a prominent role in Sen. Kennedy’s health
care plan, remembers that he “looked up one day and I hadn’t
practiced in many, many years.” He hadn’t made a conscious
decision about it, he said. “My interests had changed. What I
wanted to do in life had evolved.”
Lyman cautions that giving up one’s patients and the
one-on-one relationship is not for everyone. “There is never a
person—not a soul—that will ever see me on the street and
say, ‘Oh, thank you that I never got lung cancer!’ You have to
have that same satisfaction from looking at a graph with a line
going down.”
After decades in government, Lyman has seen governors
and legislators come and go while he and his team maintain
stability behind the scenes. That continuity, the ability to continue to contribute, is part of the satisfaction. “You don’t see us;
we are very quiet. We can’t stick our heads out very far. But we
are the ones who stay.” YM
Jenny Blair, m.d. ’04, is a writer and physician in New Haven.

Howard Koh served as public health
commissioner in Massachusetts and
is now assistant secretary for health
in the Department of Health and
Human Services in Washington.

paul fetters
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Doctors for America

A campaign by Yale alumni has amplified
doctors’ voices in the health care debate.

yale medicine autumn 2009

By Kohar Jones, m.d. ’05
In 2007, when Vivek Murthy, m.d., ’03, m.b.a. ’03, an
internist at Brigham and Women’s Hospital in Boston, was
working on then-candidate Barack Obama’s New England
steering committee, he noted how few physicians were
involved. “It was especially striking since health reform
was part of the campaign,” he said. When Obama won the
Democratic Party nomination, Murthy and fellow physicians
founded the national group Doctors for Obama.
After the election, the group changed its name to
Doctors for America (dfa) and its focus. With a private grant
sponsored by the Center for American Progress, dfa promotes health care reform and encourages physicians to speak
out on the process.
“It’s never been more important for doctors to be
engaged,” said Mandy Krauthamer Cohen, m.d. ’05, m.p.h.,
the group’s executive director.
More than 15,000 physicians have signed on in support of legislation that brings affordable insurance to all
American families, ensures high-quality care, expands access
to care, and creates practice environments that allow physicians to focus on patient care. dfa also encourages physicians
to share their stories and their ideas for change.
“Real stories speak clearly across the spectrum,” said
Murthy, president of the group. dfa leaders shared hundreds of
online comments and stories at a physician stakeholders’ meeting sponsored by the White House Office of Health Reform in
June. In October, dfa physicians were among doctors from all
50 states invited by President Obama to a Rose Garden address,
where the physicians shared their stories with the press.
Comments have focused on certain themes, Cohen
said: primary care is undervalued and under-reimbursed;
the health care system focuses on sick patients rather than
on prevention and wellness; reimbursements should reflect
time spent with patients, rather than the number of procedures completed; and the need for malpractice reform. And
90 percent of the dfa respondents supported a public option
to provide health insurance for the uninsured.
Following are responses from physicians affiliated with
the School of Medicine, including students, alumni, residents,
and faculty. YM

Q

Since April 2009, dfa
has been collecting the
responses of physicians
and medical students
around the country to
two questions:

“In the current system, what
frustrates me the most is ...”
“I want health reform that ...”
The goal is to share
physicians’ perspectives
with legislators as they
create a health care bill.
(voicesofphysicians.org)
We’d like to hear your
thoughts on health care
reform. Please send us your
ideas at ymm@yale.edu.
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What frustrates me the most is
that patients need to pay a copay for appointments, including
screening colonoscopy, which
can be as high as $500; the high
cost of prescription medication;
and the lack of a reasonable,
user-friendly electronic medical
record (emr).
I want health reform that
offers all patients a choice of
physician care and prescription
coverage; offers and encourages preventive medical care;
and brings together the many
very intelligent computer programmers in this country in a
Manhattan Project-style effort to
solve the problem of the emr.
Deborah D. Proctor, m.d.
Professor of Medicine
(Digestive Diseases)
Yale School of Medicine

In the current system, what frustrates me most is the crushing
cost of medical care at the end
of life. A significant number of
Americans die in the intensive
care unit, often after overly
aggressive procedures and
management.
I want health reform that
provides evidence-based guidelines that strictly define futile
medical care.
Curtis Weiss, m.d. ’05
Pulmonary/Critical Care Fellow,
Northwestern Memorial Hospital,
Chicago, Ill.

What frustrates me most is ...
(I can’t pick just one): gross
inequality in access to health
care; the [mistaken] idea that
all Americans have access to
health care (“After all, you just
go to an emergency room,” as
former President George W. Bush
famously stated); the de facto
rationing that occurs among
the insured and underinsured so
insurance companies can maintain steep profits; “cost-cutting
measures” that are not based
on sound biomedical evidence;
defensive medicine fueled by
unchecked litigation; the complete lack of attention to preventive health care; and the fact that
a primary care doctor working her
tail off to provide quality, costsaving care earns the smallest
salary in medicine.
I want health reform that
doesn’t placate big pharma and the
insurance industry, that is singlepayer, universal, equitable, and
focuses on health over health care.
Michael Herce, m.d. ’05, m.p.h.
Staff Physician, Abwenzi Pa Za
Umoyo/Partners in Health, Malawi
Hospitalist, Brigham & Women’s
Hospital, Boston
Instructor in Medicine, Harvard
Medical School, Boston

In the current system, what frustrates me the most is that health
care is a privilege, not a right.
I want health reform that provides care for everyone.
Auguste H. Fortin VI, m.d., m.p.h.
Associate Professor of Medicine
Yale School of Medicine

I want health reform that provides
preventive and comprehensive
services, including mental health,
to everyone in the country, with
limited bureaucracy. I also want
reform that solicits the input of
patients and physicians about
what should be covered and how
much reimbursement should be.
Carla Marienfeld, m.d.
Department of Psychiatry
Yale School of Medicine

In the current system, what
frustrates me most is that we
spend more than any country in
the world on health care and still
have embarrassingly poor population health indicators.
I want health reform that
invests in primary care to build
a health system that focuses on
prevention and population health.
Mandy Krauthamer Cohen, m.d. ’05,

m.p.h.

Executive Director, Doctors for America
Washington, D.C.

In the current system, what
frustrates me the most is that primary care medicine has become
untenable for so many physicians;
the lack of universal access to primary care; and all the wastefulness in our current system.
I want health reform that provides outstanding and accessible
primary care and specialty care
to all Americans. I want health
reform that makes the practice of
primary care medicine appealing,
manageable, and meaningful. I
want health reform that eliminates the wastefulness in our current medical system.
Anna B. Reisman, m.d.
Associate Professor of Medicine
Yale School of Medicine

In the current system, what
frustrates me the most is the
system design that interferes
with the doctor-patient relationship and places physicians’
administrative responsibilities
as a greater obligation than
time spent with patients.
I want health reform that prioritizes patients and streamlines
the paperwork done by doctors
to give us more time to dedicate
to our patients.
Youssra Marjoua
Class of 2011
Yale School of Medicine

A
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Mary Tinetti

notes

Richard Prum

Margaret Bia and Lawrence Cohen

Two faculty get
“genius” grants

A cardiologist’s last
lesson in heart sounds

mary e. tinetti, m.d. , the
Gladys Phillips Crofoot Professor
of Medicine and professor of
epidemiology and of investigative
medicine, and Richard O. Prum,
ph.d., the William Robertson
Coe Professor of Ornithology,
Ecology, and Evolutionary Biology, will each receive a five-year,
$500,000 “genius” grant from
the MacArthur Foundation.
Tinetti, director of the Yale
Program on Aging, has devoted
much of her research to fall prevention for the elderly. She was
the first investigator to show that
older adults at risk for falling and
injury could be identified, that falls
and injuries are associated with a
range of serious adverse outcomes,
and that multifaceted risk-reduction
strategies are both effective and
cost-effective. She is working to
translate these findings into clinical
and public health practice.
Tinetti has also investigated and
published extensively on functional
disability and mobility impairment.
Her most recent research focus is
on clinical decision making in the
face of multiple health conditions,
particularly trade-offs among
health conditions; the harms and
benefits of commonly recommended treatments; and the need
for universal health outcomes that
transcend individual diseases.
Prum, chair of the Department of
Ecology and Evolutionary Biology
and curator of ornithology at the
Yale Peabody Museum of Natural
History, has diverse research interests that cross many academic
boundaries. He is best known for
his studies of the development
and evolution of feathers and for
research that supports the theory
that dinosaurs were ancestors of
contemporary birds.

lawrence s. cohen, m.d., hs ’65,

taught his last class on September 15
in “Learning Heart Sounds,” a
module he has taught for 39 years.
“When I got here 30 years ago,
Larry was known in the community
as the King of Hearts,” said Margaret
J. Bia, m.d., professor of medicine
and director of the Clinical Skills
Training Program, who was present
at the class. She then presented a
gift to Cohen—a singing teddy bear
inscribed with the words “Larry
Cohen, m.d., King of Hearts.”
Cohen, the Ebenezer K. Hunt
Professor of Medicine, led the
early Yale trials of thrombolytics—
clot-busting medications used to
combat coronary disease, strokes,
and heart attacks. Since the mid1970s, Cohen has overseen some
two dozen trials of heart disease
treatments. His expertise is in
cardiology, but members of the
medical community have long
sought Cohen’s advice on a range
of topics.
In 1991, then-Dean Leon E.
Rosenberg, m.d., hs ’63, asked
Cohen to serve as deputy dean,
a role he continued to fill under
deans Robert M. Donaldson Jr.,
m.d., and Gerard N. Burrow,
m.d. ’58, hs ’66. Cohen has also
been a special advisor to three
deans, including current Dean
Robert J. Alpern, m.d., Ensign
Professor of Medicine.
Beginning in 1996, Cohen
worked with the school’s ombudsperson, Merle Waxman, m.a., to
train more than 1,000 postdoctoral
fellows, graduate students, and
faculty in ethical issues related to
the conduct of research.
Cohen continues to serve as a
faculty member and practicing cardiologist. He will remain a member
of the admissions and progress
committees and will continue in
mentorship roles.

Ronald
Adelman
Daniel L. Jacoby, m.d. ’00, assistant professor of medicine (cardiology), succeeds Cohen as instructor
of “Learning Heart Sounds.” “It is
remarkable that Larry Cohen has
left such an imprint. He comports,
with his composure and his way of
communicating, the most professional demeanor you could possibly
have as a physician,” said Jacoby,
who attended “Learning Heart
Sounds” as a medical student at
Yale in the 1990s.

Annette
Beautrais

Ronald A. Adelman, m.d., m.p.h.,
associate professor of ophthalmology and visual science, was
proclaimed a Knight of the Blind
in June by the Connecticut Lions
Eye Research Foundation. This is
the foundation’s highest award
bestowed at the state level. It was
presented in recognition of Adelman’s work in ophthalmology.
Annette Beautrais, ph.d., senior
research scientist in emergency
medicine, and Gregory L. Larkin,
m.d., professor of surgery
(emergency medicine) and vice
chair for global health and faculty development, addressed a
conference at the United Nations
in New York to launch World
Suicide Prevention Day (wspd)
on September 10. The International Association for Suicide
Prevention (iasp), in conjunction
with the World Health Organization, sponsors wspd annually
to highlight suicide prevention.
Beautrais organized wspd 2009
activities around the world in her
role as general secretary of the
iasp. wspd 2009 was launched
at the UN with a press conference and a public conference
whose theme was suicide prevention in different cultures.
Henry J. Binder, m.d., professor of
medicine (digestive diseases) and
of cellular and molecular physiology, has received a $1.8 million
grant from the Gates Foundation
to study the use of oral rehydration solutions to improve diarrhea
control worldwide. Diarrheal disease claims the lives of between
1.5 million and 2 million children
every year. Oral rehydration solution (ors) reduces mortality but
is not widely used in developing
communities for many reasons.
The 18-month planning grant will
be used to examine the supply
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Gregory
Larkin

Henry Binder

and demand for a reformulated
ors intervention and to develop
the framework for a four-year
program to address the existing
problems facing broader ors
utilization.
Irwin M. Braverman, m.d. ’55,
hs ’56, professor of dermatology, was the keynote speaker at
the Third International Medical
Education Conference sponsored
by Chung Shan Medical University in Taichung City, Taiwan,
in July. He spoke on the use of
“Fine Art to Enhance Observational Skills.” Braverman also
conducted a hands-on workshop
using reproductions of paintings
from the Yale Center for British
Art. During his visit to Taiwan he
lectured as a visiting professor in
the departments of dermatology
at Kaohsiung Medical University
and National Taiwan University
School of Medicine and at a meeting of the Taiwan Dermatology
Association.
Peter Cresswell, ph.d., a Howard
Hughes Medical Institute investigator who has spent most of
his career unraveling some of the
mysteries of the human immune
system, has been named the
Eugene Higgins Professor of
Immunobiology. Cresswell’s research focuses on the molecular
mechanisms of antigen processing, in which fragments of proteins from viruses, bacteria, and
other disease-causing organisms
bind to the major histocompatibility complex molecules on
human cells during an infection.
Myron Genel, m.d., professor
emeritus of pediatrics, recently
completed a three-year term on
the Health and Human Services
(hhs) Secretary’s Advisory Committee on Human Research

Irwin
Braverman

Ami Klin

Protections, which advises the
secretary on the responsible
conduct of research involving
human subjects. Genel received
a certificate of appreciation from
Howard K. Koh, m.d. ’77, hhs assistant secretary of health.
Ami Klin, ph.d., fw ’92, a developmental psychologist and a
world-renowned expert on severe
developmental disorders, was
named the Harris Professor of
Child Psychology and Psychiatry
in July. Klin is the director of the
Yale Child Study Center’s Autism
Program, which is dedicated to
providing comprehensive clinical
services to children with autism
spectrum disorders and their
families. The Yale psychologist
has created new methods for
studying social understanding in
young children and in individuals
with developmental disorders.
His current research focuses on
mechanisms of socialization and
their disruption in the autism
spectrum disorders.
Marvin Moser, m.d., clinical professor of medicine (cardiology),
recently retired as editor in chief
of The Journal of Clinical Hypertension and has become editor in
chief of The Medical Roundtable,
Cardiovascular Edition. The new
journal will highlight expert panels on controversial topics in cardiology. Other faculty members
who will serve as editors include
Lawrence S. Cohen, m.d., hs ’65,
the Ebenezer K. Hunt Professor of
Medicine (cardiology) Emeritus;
John F. Setaro, m.d., hs ’86,

Sara Rockwell

Gerald
Shulman

fw ’92, associate professor of

medicine (cardiology); and John
A. Elefteriades, m.d. ’76, hs ’83,
the William W.L. Glenn Professor
of Surgery (cardiothoracic).
Sara C. Rockwell, ph.d., professor
of therapeutic radiology and
pharmacology and associate dean
for scientific affairs, has been
named one of 11 astro fellows
for 2009 by the American Society
for Radiation Oncology, the
leading organization in radiation
oncology, biology, and physics.
Members of astro are eligible to
become a fellow if they have been
part of the society for at least 20
years and have shown excellence
in research, patient care, education, leadership, and service.
Rockwell, who joined the Yale
faculty in 1974, was one of the
first researchers to study the effects of hypoxia on the response
of malignant cells in culture and
solid tumors in vivo to radiation,
anticancer drugs, and combined
modality therapy.
James E. Rothman, ph.d. ’71,
chair of the Department of Cell
Biology and the Fergus F. Wallace
Professor of Biomedical Sciences,
has received a two-year $969,272
Recovery Act grant from the
National Institute of General
Medical Sciences (nigms). The
grant is part of the National
Institutes of Health Challenge
Grant initiative to jump-start a
range of research projects that
will address critical gaps in the
basic biomedical and behavioral
sciences by overcoming specific
scientific and technological challenges. Rothman’s award is one
of 19 nigms Challenge Grants
given to researchers in 12 states.
Rothman will investigate the
dynamics of membrane structure
and function in cells.

Stephen
Waxman

Gerald I. Shulman, m.d., ph.d.,
an internationally known diabetes researcher and a Howard
Hughes Medical Institute investigator, has been named the
first George R. Cowgill Professor of Physiological Chemistry.
Shulman’s research is aimed
at understanding the cellular
mechanisms of insulin resistance, the role of the liver and
muscle in the pathogenesis of
type 2 diabetes, and the benefits
of exercise in the management
of the disease.
Stephen G. Waxman, m.d.,
ph.d., the Bridget Marie Flaherty
Professor of Neurology, Neurobiology, and Pharmacology and
director of the Yale Center for
Neuroscience and Regeneration
Research at the VA Connecticut
Healthcare System, received the
Annual Review Prize, the premier
award of the British Physiological Society, in July. Waxman is
being honored for his research
on sodium channels and their
roles in multiple sclerosis, spinal
cord injury, and neuropathic pain.
Waxman delivered the Annual
Review Prize Lecture, titled “Fire,
Fantoms and Fugu: Sodium Channels From Squid to Clinic,” at the
annual meeting of the Physiological Society in Dublin, in July.
send facult y news to
Claire M. Bessinger, Yale Medicine,
300 George Street, Suite 773,
New Haven, CT 06511, or via e-mail
to claire.bessinger@yale.edu
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students
b e l o w, t o p Thomas Lynch, the head of Yale
Cancer Center, urged the class to value their connections to classmates, faculty, and patients.
b e l o w, b o t t o m In their new white coats, the
students left Sterling Hall of Medicine to pose for
a group photo on the steps of the building.

First-year class embraces
study of medicine
Ninety-nine new students don white
coats in a ceremony marking the
beginning of their medical careers.

Harkness Auditorium was aflutter with
nervous excitement on August 25 as the
Class of 2013—or “2014 or somewhere
in that vicinity,” joked Dean Robert J.
Alpern, m.d.—gathered for this year’s
White Coat Ceremony. The 99 students
in the class include 46 women and
53 men, 25 graduates of Harvard and
Yale, 19 members of ethnic or racial

groups underrepresented in medicine,
and 18 persons born outside the United
States. The group’s average mcat score
was 11.9 per section, the highest in the
school’s history. The average gpa was
3.78. “It’s an exceptionally talented and
accomplished group,” said Richard A.
Silverman, director of admissions.
Thomas J. Lynch Jr., m.d. ’86, who
came to Yale from Harvard last year to
head Yale Cancer Center and Smilow
Cancer Hospital at Yale-New Haven,
spoke to the new students on the theme
of connection—connection among
classmates, connection with faculty,
and—“since today is your White Coat
Ceremony,”—connection with patients.
“Remember how profound and wonderful the career you’ve chosen is,” Lynch
said. “I’m someone who feels incredibly privileged and lucky to be a doctor.
And I think all of you will come to that,
regardless of what type of medicine you
end up practicing.”
—Charles Gershman

r i g h t Laura Wang outside Sterling Hall of
Medicine after posing for a group photo.
fa r r i g h t Michael Alpert received his coat
from Laura Ment.

t er r y d a gr a d i ( 5 )
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a b o v e Caroline Ong smiled as she left the
stage in her white coat.
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Natasha Collins, a member of the Class
of 2012 whose classmates rallied to
find her a bone marrow donor, died on
August 12 at the age of 26.
Collins had been diagnosed with
acute myelogenous leukemia about five
years earlier and had received chemotherapy and a cord blood transplant.
When the cancer returned in February,
her classmates launched an international search for a bone marrow donor—
an effort complicated because Collins
was biracial.
“Great efforts were made to get
a match,” said Mark D. Siegel, m.d.,
fw ’95, associate professor of medicine
(pulmonary), who oversaw her care in
her final days. Siegel spoke at a meeting
in August to inform the medical school
community of the circumstances of
Collins’s passing. “Unfortunately, they
could never get a perfect match. The
leukemia got to the point where her
only chance for survival was to go with
a transplant with a slight mismatch.”
After the transplant Collins developed a severe form of a liver syndrome, which led to multiple organ
failure and her death.
Her friends, family, classmates, and
teachers gathered in Battell Chapel on
September 22 to remember and honor
her. They recalled a young woman of
promise as well as sensitivity, honesty,
compassion, joy, and warmth. They
shared memories of her playing violin in the medical school orchestra; a
homemade kale and bean soup that
went awry; and her open and honest
approach to her own cancer.

john curtis

Student loses long struggle
with leukemia despite search
for bone marrow match

“I do not believe,” said one of her
teachers, John E. Fenn, m.d., clinical
professor of surgery, “that her illness
enhanced the kindness that was already
there. … Her compassion existed irrespective of her illness.”
“It was one of my favorite moments
of each day, walking in, sitting next
to her, and seeing her smile,” said
classmate Whitney Sheen, recalling
attending lectures with Collins. Sheen
accompanied herself on the guitar and
sang a Kate Wolf song, “Across the Great
Divide,” in Collins’ honor.
“What a great doctor she would have
been,” said Nancy R. Angoff, m.p.h. ’81,
m.d. ’90, hs ’93, associate dean for
student affairs. “What better doctors
we can each be because of her. She
will shine on in us and make us better
people and better doctors.”
—John Curtis

Natasha Collins, who died in August after a bone
marrow transplant, as a first-year student in
anatomy class with one of her teachers, Cheryl
Walters, and classmate Jordan Sloshower.
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Mental illness at the
molecular level

Eric Nestler’s molecular approach
to psychiatric disorders set off a
firestorm in his department.
When Eric J. Nestler, ph.d. ’82, m.d.
’83, hs ’87, joined Yale’s Department of
Psychiatry in 1987, he ordered a sign for
his research space that read “Laboratory
of Molecular Psychiatry.”
“It was like a lightning rod,” he
recalled. “A lot of people in psychiatry
were offended because they believed
that you can’t understand psychiatric
phenomena at a molecular level.”

m at t he w s ep t imu s
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But Nestler relished his status as
a contrarian whose research countered
existing beliefs.
During his 13 years on the psychiatry faculty, where he was the Elizabeth
Mears and House Jameson Professor
of Psychiatry, Pharmacology, and
Neurobiology and director of both the
Abraham Ribicoff Research Facilities
and the Division of Molecular Psychiatry,
Nestler explored the molecular mechanisms of drug addiction and depression
in animal models. His focus was on how
drugs and stress alter brain pathways in
ways that lead to long-lasting behavioral changes. “The main contribution
that I’ve made is demonstrating a convergence among the fields of molecular
biology, neuroscience, and psychiatry,”
said Nestler. “A molecular understanding
of certain psychiatric phenomena is possible, as we’ve demonstrated specifically
for addiction and depression.”
Psychiatry, said Nestler, who is now
at the Mount Sinai School of Medicine
in New York, has often lagged behind
other medical areas in understanding the molecular underpinnings of
disease. This is due in large part to the
extraordinary complexity of the brain.
His work has helped to counteract this
trend by using state-of-the-art molecular biology tools to define disease pathogenesis, thereby helping to reintegrate
psychiatry into mainstream biomedical
science. In recognition of his accomplishments, Nestler was elected to the

Eric Nestler created a stir when he joined the
faculty in 1987 and put a sign on his door that
read “Laboratory of Molecular Psychiatry.”
Many in psychiatry, he said, took offense at the
notion that psychiatry could be understood at
the molecular level.

Institute of Medicine in 1998 and the
American Academy of Arts and Sciences
in 2005. He was also awarded the
Goldman-Rakic Prize by the National
Alliance for Research on Schizophrenia
and Depression in 2008.
Nestler arrived at Yale as an undergraduate in 1972, and he jokes that his
long history at Yale made him one of
the most Yale-degreed people around,
“but not necessarily the wisest.” He
came to Yale College from Long Island,
eager to study chemistry and biology.
Little did he know that this move would
mark the beginning of a 27-year stretch
at the university. While a junior at Yale
College, a plucky Nestler convinced Paul
Greengard, ph.d., who taught psychiatry and pharmacology at Yale from 1968
to 1983, to let him undertake research
in Greengard’s laboratory for his senior
thesis. “The opportunity to work in the
Greengard lab was one of the most
important milestones of my career,”
Nestler said. He so enjoyed his research
with Greengard, who studied cell signaling mechanisms in the nervous
system, that he continued his graduate
work there.
For his doctoral thesis, Nestler studied the role of protein phosphorylation
in the nervous system. “It was very
hard work with a lot of frustrations but,
in the end, a lot of successes. We had
some nice papers and I felt I learned
a lot and contributed something to
the lab and the field.” Indeed, Nestler
was involved in early work supporting
the argument that phosphorylation is
an important event in regulating cell
function—a discovery that garnered
Greengard the 2000 Nobel Prize in
Physiology or Medicine. “My claim to
fame is that my work was the first to
show that this process could be regulated by nerve impulses—electrical
activity in the brain—and neurotransmitters,” Nestler said. When it came
time for Nestler to set up his own lab,
he applied his study of these signaling
mechanisms to clinical psychiatry, specifically focusing on addiction in wellestablished animal models.
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A surgeon’s journey from the
early days of chemotherapy
and heart surgery

In 2000 Nestler left Yale to become
chair of psychiatry at the University
of Texas Southwestern Medical Center
at Dallas. During his tenure there,
Nestler helped develop the psychiatry
department’s basic and clinical research
programs, increasing funding from
the National Institutes of Health from
$5 million to $20 million and recruiting
many new faculty. At the same time,
Nestler managed to maintain his own
research program.
A year ago Nestler joined Mount
Sinai, where, as the director of the
Mount Sinai Brain Institute, chair of the
Department of Neuroscience, and the
Nash Family Professor of Neuroscience,
he plans to help build a novel translational neuroscience research program.
The return to the Northeast has also
allowed Nestler and his wife, Susan
De Renzo, m.p.h. ’79, to be closer to
their three children, ages 19, 21, and
23, who had come back to Connecticut
to attend college near where they grew
up. (Nestler and De Renzo met during
Friday afternoon happy hours at the
medical school, and the two have been
married for what Nestler describes as
“28 wonderful years.”) De Renzo is a
consultant for Hunter College and the
City University of New York School of
Public Health.
Looking back over his life’s accomplishments and his heterodox academic
career, Nestler said, “I consider myself
to be an extremely lucky person, both
professionally and personally.”
—Kara A. Nyberg

During his 40 years as a practicing
surgeon, Andrew J. Graham, m.d.,
fw ’65, hs ’66, witnessed the early use
of chemotherapy and experienced the
profession’s evolution from a generalist
practice to an increasingly specialized
one. When he started out, surgeons
were expected to cover a wide array of
procedures and patients. “We were true
general surgeons,” Graham said. “We
did all the emergencies, the gunshot
wounds, whatever came in.” Today, as
surgery becomes more specialized and
general surgeons become rarer, Graham
predicts difficulty for small towns and
cities that lack major medical centers
and the attendant specialist surgeons.
Through his work as an associate clinical professor of surgery and as president
of the Yale Surgical Society from its
inception in 1994 until this year, Graham
has encouraged a generalist’s comprehensive view of surgery’s mission and its
capacity to care for patients.
His introduction to medicine began
with the inspiration of his future brotherin-law, a general practitioner and former
mash doctor in the European Theater
during World War II, who pursued a
solo practice in Lexington, Mass. They
met when Graham was an officer in
the U.S. Navy. In 1956, upon entering
Tufts School of Medicine, Graham lived
with his wife and infant son in an apartment above the practice. He occasionally accompanied his brother-in-law
on house calls to nearby farms and
helped perform circumcisions in the
office on Saturdays.
Graham was still a fourth-year medical student when he came to New Haven
for the surgical rotation that would
determine the course of his career.
It was 1959, and Gustaf E. Lindskog,
m.d., was the chief of surgery at
Grace-New Haven Hospital. Working
with Lindskog affirmed Graham’s
decision to become a surgeon. “On
the surgical rotation, if you had a

problem, you solved it if you could,”
he said. “The medical rotations were
endless rounds of people trying to show
how smart they were.” Lindskog invited
Graham to stay for a subinternship and
later, for residency. Training was rigorous, with many interns working under a
few chiefs. By the time he was chief resident himself, the attending physicians
“would come by once a week, just to see
what we were doing.” Otherwise, the
residents carried their own caseloads.
In 1965, Graham was the oncologic
fellow for section chief Mark Hayes,
m.d., and helped administer chemotherapy, then still an experimental
treatment, under the direction of Paul
Calabresi, m.d. ’55, “We made people
sick because we didn’t know what we
were doing,” he said. Because oncologic
medicine was part of general surgery at
that time, it fell to surgeons to administer chemotherapy. And because there
was no hospice, dying surgical cancer
patients would find care on general
surgical floors. Graham said, “We
would take care of them all the way.”
After his residency, Graham went
into solo private practice as a general
surgeon in New Haven. A year later fellow surgeons and house staff alumni
Richard A. Selzer, m.d., hs ’61, and
Bernie S. Siegel, m.d., hs ’61, invited
him to join their practice. Although he
no longer performs surgeries, Graham
remains on staff as a consulting physician. He also invites third-year Yale
medical students to visit his practice
for a 12-week mentorship program that
exposes them to aspects of medicine
often missing from a hospital rotation.
“They find out there are a lot of little
things that never come into the hospital,
like a thrombosed hemorrhoid,” Graham
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When Andrew Graham became a surgeon in
the 1960s, he was expected to do everything—
“whatever came in.” As a professor of surgery
and as president of the Yale Surgical Society for
15 years, he encouraged a generalist’s view.
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spring yale service
tour to mexico

said. “Most of the residents don’t know
what to do with that problem, since
they’ve never seen it.” Showing the students “the big picture of medicine”—
about caring for the whole patient in a
surgical context—is Graham’s way of
explaining why it is important to be a
general surgeon. He feels that the mentorship program run by the Department
of Surgery is a wonderful way to bring
“young sponges” into the field.
As president of the Yale Surgical
Society, Graham has led the society’s
efforts both to honor the surgical faculty
and residents and to appeal to medical students considering surgery. This
year, Graham stepped down from his
15-year post. (The Surgical Society’s new
bylaws specify that officers’ posts will
be changed every two years.) Graham
will remain involved with the society but
hopes to devote more time to his wife of
54 years, traveling, gardening, visiting
grandchildren, and mentoring students

in his office and at the anatomy lab.
“If someone is thinking about surgery,”
Graham said, he tells them, “You have
to see if you love it. … It’s a tough taskmaster, and you have to be strong mentally and physically, because operating
and caring for patients requires a total
unconditional commitment. … But I’ve
been very lucky.”
—Ayelet Amittay

Familiar Faces

Do you have a colleague who is making
a difference in medicine or has followed
an unusual path since leaving Yale? We’d
like to hear about alumni of the School of
Medicine; Physician Associate Program;
and the medical school’s doctoral, fellowship, and residency programs. Drop us a
line at ymm@yale.edu or write to Faces,
Yale Medicine, 300 George Street, Suite
773, New Haven, CT 06511.

Yale Service Tours provide a vehicle for Yale
alumni, students, and their families to join
in global service. Service Tours allow alumni
to apply their diverse skills to projects in
medical clinics, clinical home/community
assessment and support, education, consulting, sustainability programs, public works,
arts enrichment, athletics, and more. The
Association of Yale Alumni collaborates with
local partners and alumni leaders to utilize
the skills of alumni volunteers in meeting
each community’s needs. Yale Service
Tours programs also provide unparalleled
opportunities to connect with people in
the local community, learn in depth about
the populations we serve, and form close
bonds with fellow alumni who share a passion for service.

save the date

2010 Yale Service Tour to Monterrey, Mexico
March 13–21, 2010
In collaboration with Tecnológico de
Monterrey, a private Mexican educational
institution founded in 1943.

for more information
www.YaleServiceTours.org
Contact: Remy Shaber
Service Tour Coordinator
Association of Yale Alumni
203-432-1955
remy.shaber@yale.edu
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Elizabeth
Blackburn

Howard Koh

Former Yale postdoc
shares 2009 Nobel for
research on telomeres

1950s

elizabeth h. blackburn, ph.d.,
fw ’77, sc.d.h. ’91, the Morris

Herzstein Professor of Biology
and Physiology at the University
of California, San Francisco, was
one of three American scientists
to share the 2009 Nobel Prize in
Physiology or Medicine “for the
discovery of how chromosomes
are protected by telomeres and
the enzyme telomerase.”
Blackburn began her research
on telomerase while she was
a postdoctoral fellow at Yale.
She shares the Nobel award with
Carol W. Greider, ph.d., of Johns
Hopkins, and Jack W. Szostak,
ph.d., of Harvard, both of whom
shared the Albert Lasker Basic
Medical Research Award with her
in 2006.
The citation from the Nobel
Foundation stated, “This year’s
Nobel Prize in Physiology or Medicine is awarded to three scientists
who have solved a major problem
in biology: how the chromosomes
can be copied in a complete way
during cell divisions and how they
are protected against degradation.
The Nobel Laureates have shown
that the solution is to be found in
the ends of the chromosomes—
the telomeres—and in an enzyme
that forms them—telomerase.”
Blackburn earned her doctorate
from the University of Cambridge
in England in 1975 and did her postdoctoral work at Yale from 1975 to
1977 in molecular and cellular biology in the laboratory of another
2006 Lasker honoree, Joseph G.
Gall, ph.d. ’52.

Eliot Sorel

Robert J.T. Joy, m.d. ’54, received
an honorary doctor of military
medicine degree from the Uniformed Services University (usu)
of the Health Sciences at their
30th Commencement in May.
Joy was honored for his contributions to the academic discipline
of military medicine. Joy, who
lives in Chevy Chase, Md., served
in the U.S. Army from 1954 to 1981
and was founding commander
of the Army Research Institute of
Environmental Medicine. He held
senior staff positions in medical
research in the office of the Army
Surgeon General and in the Office
of the Secretary of Defense.
In 1981 he founded the Department of Medical History at usu
and became professor emeritus
in 1996.

1960s
James S. Dalsimer, m.d. ’63, and
Ellen Steinbaum, a poet and
writer in Cambridge, Mass., were
married on August 18 on Mount
Desert Island, Maine. Dalsimer is
a psychiatrist and psychoanalyst
in private practice in Cambridge
and a clinical instructor in
psychiatry at Harvard Medical
School. Steinbaum has written
two books of poetry and until
recently wrote a literary column
for the Boston Globe.

1970s
Howard Koh, m.d. ’77, m.p.h., has
been named assistant secretary
for health at the U.S. Department of Health and Human
Services. The assistant secretary
serves as the Secretary of Health
and Human Services’ primary advisor on matters involving public
health. Koh was previously the

Brian Nahed and Vanessa Kerry

Harvey V. Fineberg Professor of
the Practice of Public Health and
associate dean for public health
practice at the Harvard School
of Public Health. He also served
as the Massachusetts Commissioner of Public Health from 1997
to 2003.
Eliot Sorel, m.d., fw ’75, was appointed a council member of the
Woodrow Wilson International
Center for Scholars in Washington, D.C., in June. And in October
he was awarded an honorary
degree by the Carol Davila University of Medicine and Pharmacy
at the Romanian Athenaeum
in Bucharest, Romania. Sorel is
clinical professor of global health,
health services management
and leadership, and psychiatry
and behavioral sciences at the
George Washington University in
Washington, D.C.

1990s
Samuel S. Myers, m.d. ’92,
m.p.h., an instructor of medicine at Harvard Medical School
and research associate at the
Harvard University Center for
the Environment, is the author
of Global Environmental Change:
The Threat to Human Health, a
report published in November by
the Worldwatch Institute and the
United Nations Foundation. The
report outlines a series of public
health threats caused by climate
change—food and water scarcity,
altered distribution of infectious
diseases, increased air pollution,

natural disasters, and population
displacement—that threaten
large segments of the human
population. The report outlines
the need for national-level risk
assessments to identify the greatest threats in different regions, as
well as unprecedented technical
and financial assistance from the
international community to help
developing countries adapt to the
health impacts of accelerating
environmental change.

2000s
Brian V. Nahed, m.d. ’05, was
married in October to Vanessa
B. Kerry, m.d., in Boston. Both
are residents at Massachusetts
General Hospital, where they
met in 2005. He is in his fifth year
of a residency in neurosurgery.
Kerry, who is in her third year of
a residency in internal medicine,
is a daughter of Sen. John Kerry, a
Democrat from Massachusetts.
Arvind Venkat, m.d. ’00, was
promoted to associate professor
of emergency medicine at the
Drexel University College of Medicine in Philadelphia, effective July
1, 2009. Venkat is the director
of research in the Department
of Emergency Medicine and an
ethics consultant at Allegheny
General Hospital in Pittsburgh,
Penn. The hospital is a regional
campus of Drexel.
send alumni news to
Claire M. Bessinger, Yale Medicine,
300 George Street, Suite 773,
New Haven, CT 06511, or via e-mail
to claire.bessinger@yale.edu
visit us on the web
yalemedicine.yale.edu
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in memoriam

Lane Ameen, m.d., associate clinical professor of psychiatry, died at
his home in New Haven on June 13
after a brief illness. He was 85.
Ameen was also a fellow of Jonathan Edwards College at Yale and
medical director and ceo of a
private psychiatric hospital. He
came to Yale in the 1950s and
remained for his entire career. His
early research focused on schizophrenia, psychosomatic disorders,
and traditional psychotherapeutic
methods of the Freudian era. He
was later influenced by emerging
psychopharmacological studies
and contemporary treatments.
Ronald W. Cooke, m.d. ’43, hs ’49,
died on August 16 in Castine, Maine.
He was 90. After a pediatrics
residency at Strong Memorial
Hospital in Rochester, N.Y., Cooke
entered the Army and served
at Walter Reed Hospital and on
a hospital ship. He practiced
pediatric surgery for 30 years at
Hartford Hospital, Newington
Children’s Hospital, and the
University of Connecticut Health
Center.

yale medicine winter 2010

Lloyd M. Felmly, m.d. ’50, died on
September 3 in Carrollton, Ga.
He was 89. Felmly began medical
school at Yale in 1941 but enlisted
in the U.S. Navy in January 1942.
Following World War II, Felmly
returned to medical school. He
practiced briefly in New Jersey
before moving to upstate New
York, where he practiced for more
than 40 years.
Angela R. Holder, j.d., ll.m. ’75,
former clinical professor of
pediatrics (law) at the School
of Medicine, the Institution
for Social and Policy Studies at
Yale, and Yale Law School, died
on April 22 at her home in Durham, N.C. She was 71. Holder’s

research and teaching focused on
ethical and legal issues in human
subjects research, pediatrics,
adolescent medicine, and human
reproduction. Among her publications is The Meaning of the
Constitution, a text for undergraduates currently in its sixth edition.
Holder spent her first year of law
school as an exchange student
at King’s College, London, and
received her law degree from
Tulane Law School. From 1975 to
1977, she was executive director
of the Program in Law, Science,
and Medicine at Yale Law School.
From 2001 until her retirement in
2007, she was professor of the
practice of medical ethics and
humanities in the Trent Center for
Bioethics, Humanities, and History
of Medicine at Duke University
Medical Center. She authored
four books and numerous published articles. One of the most
meaningful honors she received,
according to her son, John, was
being selected by the medical
school Class of 1988 as their Commencement speaker. She also
enjoyed impersonations of her in
the annual second-year show.
Ruth S. Kempe, m.d. ’46, hs ’49,
a former professor of psychiatry
and pediatrics at the University of
Colorado School of Medicine and
an advocate for abused children,
died on July 24 in Denver. She was
87. With her husband, the late C.
Henry Kempe, m.d., hs ’49, she
worked at the Kempe Center for
the Prevention and Treatment of
Child Abuse and Neglect. Kempe
and her husband were co-authors
of several books, including
Healthy Babies; Happy Parents.

Raymond Mark, m.d. ’59, died on
September 16 of natural causes
at his home in Royersford, Penn.
He was 78. After medical school,
Mark completed a fellowship in
pathology and immunology at
Duke University Medical School
and a residency in pathology
at the University of Pittsburgh
School of Medicine. As an immunologist he was involved in the
university’s early heart transplant
program.
C.P. Noel McCarthy, m.d., m.p.h.
’70, former associate clinical
professor of obstetrics and gynecology, died on July 22 in New
Haven. He was 73. McCarthy was
an integral part of the Department of Obstetrics, Gynecology,
and Reproductive Sciences since
1967. He performed his medical
internship and residency in
obstetrics and gynecology at the
Hospital of St. Raphael in New
Haven and was a fellow in infertility and gynecologic infertility
at Yale-New Haven Hospital. In
1968 he became a clinical instructor. He later became an associate
clinical professor, a position he
held until his retirement in 2004.
During that period, McCarthy
also served as assistant chair of
the Department of Obstetrics
and Gynecology at the Hospital
of St. Raphael.
Warwick Potter, m.d. ’53, died
on August 5 of complications of
emphysema in Wellesley, Mass.
He was 82. After a residency at
Children’s Hospital in Boston,
Potter was a pediatrician in Ipswich, Mass., and an emergency
room physician at Parkland
Medical Center in Derry, N.H.,
and Marlborough Hospital in
Massachusetts.

Marcus E. Sanford, m.d. ’43, died
on September 3 in Somerville, N.J.
He was 91. During World War II
Sanford was a captain in the Army
Medical Corps. He was a prominent physician in Somerville for
45 years. He retired in 1991.
Julie K. Staley-Gottschalk, ph.d.,
associate professor of psychiatry
and director of the Department
of Psychiatry’s spect Imaging program, died on July 25 of cancer in
New Haven. She was 44. StaleyGottschalk came to Yale in 1997
to complete a two-year postdoctoral fellowship in neurochemical
brain imaging in the Department
of Psychiatry at the VA Connecticut Healthcare System in West
Haven. Her research focused
on the use of neuroimaging to
understand the molecular causes
and consequences of nicotine dependence, alcoholism, depression,
and other psychiatric disorders.
Her contributions were recognized by the Society of Biological
Psychiatry and the Dana Clinical
Hypothesis Program in Brain and
Immuno-Imaging Award.
send obituary notices to
Claire M. Bessinger, Yale Medicine,
300 George Street, Suite 773,
New Haven, CT 06511, or via e-mail
to claire.bessinger@yale.edu
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On the last Wednesday in August, dozens of new medical students
tried their luck against their classmates, second-year colleagues, and
teachers on Casino Night, held at Marigold’s. The students took
their chances in blackjack, Texas hold ’em, and roulette—with faculty
members as dealers and croupiers.
As it happens—and all concerned say it is a coincidence—
the new students attend their first anatomy class on the day following their night of gambling. That first day with a cadaver can be
emotionally trying for students, according to anatomy faculty, who
say it helps to meet the students beforehand in a casual setting.
“We meet them in a friendlier, more relaxed atmosphere,”
said Lawrence J. Rizzolo, who leads the anatomy course with
William B. Stewart.
The Medical Student Council has organized the Casino Night
event for more than a decade. Those wishing to wager pay $5 for a
stack of funny money that features the faces of faculty, including
Dean Robert J. Alpern, on the bills. Faculty members like to check out
who appears on the bills—it’s a reflection of their standing with the
students, Rizzolo joked.
Adam Sang, a second-year student and one of the organizers
of the event, said the evening is a welcome break from the “training
and talking” of the orientation period. “Last year it was one of the
most fun events for first-years.”
Among the dealers and croupiers at this year’s Casino Night
were Alpern, as well as anatomy teachers Shanta E. Kapadia and
Michael K. O’Brien, Auguste H. Fortin, Karen Jubanyik, and, of course,
Stewart and Rizzolo.
—John Curtis

john curtis

O N TH E E V E O F CL A SS, A G A M E O F CH A N CE

Vivek Kulkarni, Jovana Pavisic, Vladimir Glinskii,
and Michelle Chen played blackjack at Casino
Night in August. The annual student-run event
serves as an icebreaker for students and faculty,
particularly in anatomy. By coincidence, firstyear students have their first class in anatomy
on the following day.

